• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

ALI’s second-quarter revenues skyrocket

Article

ALI Technologies, of Richmond, British Columbia, continues to reap the rewards of a healthy PACS market. The ultrasound miniPACS developer posted revenues of $3.1 million (Canadian) for the second quarter of fiscal 1997 (end-March 31), a 92% increase

ALI Technologies, of Richmond, British Columbia, continues to reap the rewards of a healthy PACS market. The ultrasound miniPACS developer posted revenues of $3.1 million (Canadian) for the second quarter of fiscal 1997 (end-March 31), a 92% increase over the $1.6 million reported in the same period in 1996. Net income was $457,000 versus $6000 netted in the 1996 fiscal second quarter.

ALI celebrated several accomplishments in the second quarter, highlighted by the announcement that GE Medical Systems would purchase up to 19.9% of ALI's outstanding equity (SCAN 4/2/97). Negotiation over final documentation of the deal is ongoing, according to the company.

Other notable achievements in the second quarter included the first shipments of the UltraPACS 3.0 upgrade as well as the vendor's SWS 250 notebook PC-based sonographers' workstation. The company installed nine UltraPACS systems in the second quarter, seven of which were in North America.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.